Mavrilimumab (Anti-CSF2Ra/GM-CSFRa/CD116)
Mavrilimumab (Anti-CSF2Ra/GM-CSFRa/CD116) is a monoclonal antibody that binds to the α subunit of the granulocyte-macrophage colony stimulating factor (GM-CSF) receptor and blocks intracellular signalling downstream of GM-CSF. MW: 145.5 KD.
Trivial name | CAM 3001 |
Catalog Number | A2532 |
CAS# | 1085337-57-0 |
Size | 1mg*25 |
Supplier Page | http://www.selleckchem.com/products/mavrilimumab-anti-csf2ra-gm-csfra-cd116.html |